Operating
Net losses on financial instruments
Elevance Health Net losses on financial instruments decreased by 36.8% to -$78.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 83.2%, from -$464.00M to -$78.00M. Over 4 years (FY 2021 to FY 2025), Net losses on financial instruments shows a downward trend with a 19.3% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ1 2020
Last reportedQ1 2026Apr 22, 2026
How to read this metric
High volatility in this metric can obscure core operational performance, as it reflects market fluctuations rather than business activity.
Detailed definition
This metric captures the non-cash impact of changes in the fair value of financial instruments held by the company. It r...
Peer comparison
Common in financial services and insurance sectors where investment portfolios are significant.
Metric ID:
operating_net_losses_gains_on_financial_instrumentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $172.00M | -$61.00M | $211.00M | -$151.00M | -$231.00M | -$57.00M | -$111.00M | -$113.00M | -$121.00M | -$124.00M | -$336.00M | -$161.00M | -$85.00M | -$125.00M | -$74.00M | -$464.00M | -$131.00M | -$1.00M | -$57.00M | -$78.00M |
| QoQ Change | — | -135.5% | +445.9% | -171.6% | -53.0% | +75.3% | -94.7% | -1.8% | -7.1% | -2.5% | -171.0% | +52.1% | +47.2% | -47.1% | +40.8% | -527.0% | +71.8% | +99.2% | <-999% | -36.8% |
| YoY Change | — | — | — | — | -234.3% | +6.6% | -152.6% | +25.2% | +47.6% | -117.5% | -202.7% | -42.5% | +29.8% | -0.8% | +78.0% | -188.2% | -54.1% | +99.2% | +23.0% | +83.2% |
Range-$464.00M – $211.00M
CAGR-15.3%
Avg YoY Growth-37.5%
Median YoY Growth+2.9%
Current Streak2 quarters decline
Business Segments
| Segment | Q1 '25 |
|---|---|
| Reportable Segments | -$464.00M |
| Total | -$464.00M |
Net losses on financial instruments at Other Companies
Frequently Asked Questions
- What is Elevance Health's net losses on financial instruments?
- Elevance Health (ELV) reported net losses on financial instruments of -$78.00M in Q1 2026.
- How has Elevance Health's net losses on financial instruments changed year-over-year?
- Elevance Health's net losses on financial instruments increased by 83.2% year-over-year, from -$464.00M to -$78.00M.
- What is the long-term trend for Elevance Health's net losses on financial instruments?
- Over 4 years (2021 to 2025), Elevance Health's net losses on financial instruments has grown at a 19.3% compound annual growth rate (CAGR), from $322.00M to -$653.00M.
- What does net losses on financial instruments mean?
- Non-cash gains or losses resulting from changes in the value of financial investments.